Cargando…
Blocking Activin Receptor Ligands Is Not Sufficient to Rescue Cancer-Associated Gut Microbiota—A Role for Gut Microbial Flagellin in Colorectal Cancer and Cachexia?
Colorectal cancer (CRC) and cachexia are associated with the gut microbiota and microbial surface molecules. We characterized the CRC-associated microbiota and investigated whether cachexia affects the microbiota composition. Further, we examined the possible relationship between the microbial surfa...
Autores principales: | Pekkala, Satu, Keskitalo, Anniina, Kettunen, Emilia, Lensu, Sanna, Nykänen, Noora, Kuopio, Teijo, Ritvos, Olli, Hentilä, Jaakko, Nissinen, Tuuli A., Hulmi, Juha J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896205/ https://www.ncbi.nlm.nih.gov/pubmed/31731747 http://dx.doi.org/10.3390/cancers11111799 |
Ejemplares similares
-
Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver
por: Hentilä, Jaakko, et al.
Publicado: (2019) -
Muscle NAD(+) depletion and Serpina3n as molecular determinants of murine cancer cachexia—the effects of blocking myostatin and activins
por: Hulmi, J.J., et al.
Publicado: (2020) -
Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses
por: Nissinen, Tuuli A., et al.
Publicado: (2018) -
Gut Microbiota, Microbial Metabolites and Human Physical Performance
por: Lensu, Sanna, et al.
Publicado: (2021) -
Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments
por: Hulmi, Juha J., et al.
Publicado: (2021)